C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes

Circulation

Volumn 109, Issue 21, 2004, Pages 2566-2571

  Han, Ki Hoon ^a   Hong, Kyung Hee ^a   Park, Jae Hyeong ^a   Ko, Jesang ^a   Kang, Duk Hyun ^a   Choi, Kee Joon ^a   Hong, Myeong Ki ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Atherosclerosis; C reactive protein; Chemotaxis; Monocytes

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR2; FC RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE D1;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOTAXIS; CHOLESTEROL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASE D; RECEPTORS, CHEMOKINE; RECEPTORS, IGG; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 2642518797     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000131160.94926.6E     Document Type: Article

References (20)

1. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
2. Chang MK, Binder CJ, Torzewski M, et al. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA. 2002;99:13043-13048.
3. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370-372.
4. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812.
5. Boring L, Gosling J, Cleary M, et al. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherogenesis. Nature. 1998;394:894-897.
6. Han KH, Chang MK, Boullier A, et al. Oxidized LDL reduces monocyte CCR2 expression through pathways inyolving peroxisome proliferator-activated receptor gamma. J Clin Invest. 2000;106:793-802.
7. Melendez A, Bruetschy L, Floto RA, et al. Functional coupling of FcγRI to nicotinamide adenine dinucleotide phosphate (reduced form) oxidative burst and immune complex trafficking requires the activation of phospholipase D1. Blood. 2001;98:3421-3428.
8. Han KH, Tangirala RK, Green SR, et al. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1 mediated chemotaxis in human monocytes: a regulatory role for plasma low-density lipoprotein. Arterioscler Thromb Vasc Biol. 1998;18:1983-1991.
9. Tangirala RK, Murao K, Quehenberger O. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem. 1997;272:8050-8056.
10. Sica A, Saccani A, Borsatti A, et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med. 1997;185:969-974.
11. Crowell RE, Du Clos TW, Montoya G, et al. C-reactive protein receptors on the human monocyte cell line U-937: evidence for additional binding to FcγRIII. J Immunol. 1991;147:3445-3451.
12. Bharadwaj D, Stein MP, Volzer M, et al. The major receptor for C-reactive protein on leukocytes is FcγRII. J Exp Med. 1999;190:585-590.
13. Khreiss T, Jozsef L, Hossain S, et al. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem. 2002;277:40775-40781.
14. Randolph GJ, Sanchez-Schmitz G, Liebman RM, et al. The CD16(+)(FcγRIII(+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med. 2002;196:517-527.
15. Fleit HB, Kobasiuk CD. The human monocyte-like cell line THP-1 expresses FcγRI and FcγRII. J Leukoc Biol. 1991;49:556-565.
16. Melendez A, Floto RA, Cameron AJ, et al. A molecular switch changes the signaling pathway used by the FcγRI antibody receptor to mobilise calcium. Current Biol. 1998;8:210-221.
17. Bodman-Smith KB, Melendez A, Campbell I, et al. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI). Immunology. 2002;107:252-260.
18. Gibbs TC, Meier KE. Expression and regulation of phospholipase D (PLD) isoforms in mammalian lines. J Cell Physiol. 2000;182:77-87.
19. Woollard KJ, Phillips DC, Griffiths HR. Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol. 2002;130:256-262.
20. Chang JW, Yang WS, Min WK, et al. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis. 2002;39:1213-1217.